TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 5.67%21.14B | -19.85%43.31B | -36.79%20B | -26.01%54.03B | -17.99%31.64B | -8.99%73.03B | 15.09%38.59B | 33.21%80.25B | 23.65%33.53B | 7.29%60.24B |
Operating income | 5.67%21.14B | -19.85%43.31B | -36.79%20B | -26.01%54.03B | -17.99%31.64B | -8.99%73.03B | 15.09%38.59B | 33.21%80.25B | 23.65%33.53B | 7.29%60.24B |
Cost of sales | -27.85%-23.01B | 17.34%-43.83B | 25.78%-18B | 1.80%-53.03B | 12.59%-24.25B | 3.80%-54.01B | -26.05%-27.74B | -34.05%-56.14B | -16.47%-22.01B | -33.08%-41.88B |
Operating expenses | -27.85%-23.01B | 17.34%-43.83B | 25.78%-18B | 1.80%-53.03B | 12.59%-24.25B | 3.80%-54.01B | -26.05%-27.74B | -34.05%-56.14B | -16.47%-22.01B | -33.08%-41.88B |
Gross profit | -193.18%-1.87B | -152.39%-524.42M | -72.87%2.01B | -94.74%1B | -31.80%7.4B | -21.08%19.02B | -5.83%10.85B | 31.29%24.1B | 40.15%11.52B | -25.60%18.36B |
Selling expenses | 9.78%-664.42M | 11.58%-1.09B | 26.97%-736.42M | 60.26%-1.23B | 20.82%-1.01B | -30.09%-3.1B | -33.76%-1.27B | -17.69%-2.38B | 0.70%-952.07M | 12.59%-2.03B |
Administrative expenses | 35.65%-924.55M | 10.75%-3.84B | 16.26%-1.44B | -7.52%-4.31B | 9.68%-1.72B | 23.51%-4B | -10.85%-1.9B | -30.90%-5.23B | -23.24%-1.71B | -37.44%-4B |
Impairment and provision | 87.62%-83.87M | 47.67%-1.62B | -20.06%-677.52M | -279.45%-3.09B | -184.68%-564.3M | -43.64%-813.98M | -102.01%-198.22M | -278.86%-566.68M | -66.78%-98.13M | -53.80%-149.57M |
-Other impairment is provision | 87.62%-83.87M | 47.67%-1.62B | -20.06%-677.52M | -279.45%-3.09B | -184.68%-564.3M | -43.64%-813.98M | -102.01%-198.22M | -278.86%-566.68M | -66.78%-98.13M | -53.80%-149.57M |
Special items of operating profit | -81.20%-1.31B | -322.92%-2.48B | -119.42%-724.35M | -82.65%1.11B | -24.33%3.73B | 28.07%6.42B | 41.56%4.93B | -14.45%5.01B | -32.59%3.48B | 111.48%5.86B |
Operating profit | -209.64%-4.86B | -46.72%-9.56B | -120.00%-1.57B | -137.18%-6.51B | -36.81%7.84B | -16.29%17.52B | 1.37%12.41B | 16.00%20.93B | 11.49%12.24B | -18.44%18.04B |
Financing cost | 53.44%-497.78M | 72.56%-851.2M | 25.77%-1.07B | -119.30%-3.1B | -16.21%-1.44B | -35.98%-1.41B | 7.67%-1.24B | 58.88%-1.04B | -45.01%-1.34B | 7.82%-2.53B |
Special items of earning before tax | 21.18%-265.83M | -90.65%-1.44B | 4.38%-337.25M | -195.37%-757.45M | -280.31%-352.72M | -49.91%794.24M | -60.17%195.62M | 45.97%1.59B | 226.78%491.12M | 3,908.58%1.09B |
Earning before tax | -88.92%-5.62B | -14.26%-11.85B | -149.19%-2.97B | -161.38%-10.37B | -46.78%6.05B | -21.31%16.9B | -0.22%11.36B | 29.38%21.47B | 11.62%11.39B | -14.46%16.6B |
Tax | -415.47%-3.28B | 69.14%-926.25M | 76.36%-636.56M | 61.52%-3B | 44.96%-2.69B | 15.44%-7.8B | 3.10%-4.89B | -25.26%-9.22B | -17.18%-5.05B | 33.33%-7.36B |
After-tax profit from continuing operations | -146.48%-8.9B | 4.46%-12.78B | -207.66%-3.61B | -246.99%-13.37B | -48.16%3.35B | -25.72%9.1B | 2.07%6.47B | 32.66%12.25B | 7.56%6.34B | 10.47%9.23B |
Earning after tax | -146.48%-8.9B | 4.46%-12.78B | -207.66%-3.61B | -246.99%-13.37B | -48.16%3.35B | -25.72%9.1B | 2.07%6.47B | 32.66%12.25B | 7.56%6.34B | 10.47%9.23B |
Minority profit | -29.50%248.75M | -102.78%-17.05M | -26.03%352.83M | -56.31%612.56M | -29.10%477.01M | -17.06%1.4B | 1.58%672.79M | 94.04%1.69B | 65.70%662.33M | 56.72%871.23M |
Profit attributable to shareholders | -130.82%-9.15B | 8.77%-12.76B | -237.77%-3.96B | -281.73%-13.99B | -50.38%2.88B | -27.11%7.7B | 2.13%5.8B | 26.27%10.56B | 3.33%5.68B | 7.18%8.36B |
Basic earnings per share | -99.07%-1.917 | 24.93%-2.873 | -255.83%-0.963 | -321.34%-3.827 | -54.66%0.618 | -29.14%1.729 | 3.18%1.363 | 26.10%2.44 | 0.99%1.321 | 5.45%1.935 |
Diluted earnings per share | -99.07%-1.917 | 24.93%-2.873 | -255.83%-0.963 | -321.34%-3.827 | -54.66%0.618 | -29.14%1.729 | 3.18%1.363 | 26.10%2.44 | 0.99%1.321 | 5.45%1.935 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.